• by bcarlson@marketresearch.com
  • June 26 2014
  • vaccines


Federal Judge OKs Public School Vaccine Requirement

Federal Judge OKs Public School Vaccine Requirement

A New York City policy that bars unvaccinated students from public school when another student has a vaccine-preventable disease has been upheld by Judge William Kuntz II of the of Federal District Court in Brooklyn. The decision’s reasoning is anchored both in the mechanism of vaccine products and the business behind them covered in Kalorama’s recent report, Vaccines 2014.

Religious objectors are not constitutionally exempt from vaccinations," said Kuntz, citing a 109-year-old Supreme Court r...

  • by bcarlson@marketresearch.com
  • June 23 2014
  • EHR
  • EMR


Epic Makes Inroads: Kalorama EMR as Covered in Healthcare IT News

Epic Makes Inroads: Kalorama EMR as Covered in Healthcare IT News

A Healthcare IT News story citing Kalorama’s estimates of the Electronic Medical Records Market notes that once-small provider Epic has moved into the top three position in EMR, according to our analysis. The Wisconsin-based company is private, but has consistently picked up large hospital systems with large physician affiliate bases, and expanded services within these systems. The article references managment problems at rival Allscripts for partially explaining Epic’s share position. This refl...


Pillars of U.S. Physician Office Testing - Urinalysis

Pillars of U.S. Physician Office Testing - Urinalysis

A given in near every general practitioner’s office or primary clinic, dipstick urinalysis requires only a disposable collection cup, test strip, and sink. The test is routine, simple, multiplexed and extremely low-cost (strips cost $0.05 or less each) - tested parameters include urine bilirubin, glucose, hemoglobin, ketone, leukocytes, nitrites, pH, protein, specific gravity and urobilinogen. Similar to more complex chemistry panels, dipstick urinalysis can alert clinicians to multiple conditio...

  • by bcarlson@marketresearch.com
  • June 16 2014


Medtronic-Covidien Deal Could Create World’s Largest Device Company

Medtronic-Covidien Deal Could Create World’s Largest Device Company

A bid to unseat Johnson and Johnson as the world’s largest device company is underway. US-based Medtronic said it would purchase Ireland-based Covidien for $42.9 billion, combining two of the world’s biggest medical device makers and helping Medtronic lower some taxes by gaining access to cash held overseas. Kalorama estimates the deal will come just short of creating the largest device company based on 2013 revenues in our Device Bellwether Index. The two companies earned a combined 28.2 billio...


Recapping the ’Doc Fix’ Act’s Impacts on Medicare Lab Reimbursement

Recapping the ’Doc Fix’ Act’s Impacts on Medicare Lab Reimbursement

The clinical lab and IVD industries continue to assess the “Doc Fix” Bill or Protecting Access to Medicare Act of 2014 (H.R. 4032) following its passage in April 2014. The law, to be implemented by 2017, has seen no shortage of reactions from stakeholders. Under its provisions, the Act will allow CMS to systematically collect test payment rate and volume data from “applicable” private labs, including at least reference or commercial labs and likely hospital labs (or those with outreach businesse...


How to Know When Biotech is Booming? The Need to Train Non-Scientists

How to Know When Biotech is Booming?  The Need to Train Non-Scientists

Kalorama knows there’s more than one way to detect market growth. Company results and investment dollars tell tales, but tangential trends often indicate large market movement. the mortgage boom can be seen with an influx of new mortgage providers. A boom in real estate can be seen in the amount of people becoming realtors. In the case of biotech, could it be, the need to learn DNA with Lego? We know ( our recent biotech report finds it ) there is an increase in interest and funding of biotech 2...


With Home HbA1c Testing, Industry Won’t Give Up the Ghost

With Home HbA1c Testing, Industry Won’t Give Up the Ghost

Glycated hemoglobin (HbA1c or simply A1c) is one the greatest clinical and IVD industry success stories of the past decade, but has faltered on one front - home testing or patient self-testing. A seemingly natural extension of self-monitoring of blood glucose (SMBG), the market for CLIA-waived home use HbA1c tests has struggled through significant field testing error (and lot-to-lot variation in studies), limited reimbursement coverage, and a lack of resonance with patients and clinicians. Yet, ...

  • by bcarlson@marketresearch.com
  • June 2 2014


Measles Scare Highlights Need for Vaccination

Measles Scare Highlights Need for Vaccination

Fourteen years ago, measles was eradicated in the United States. That was good news, as it is often forgotten that this is a highly contagious respiratory disease. Now, a 20-year high caseload has brought fears of the epidemic’s return to this country. The case increase is largely the result of vaccine refusal, according to CDC reports. The US has seen an 288 cases so far in 2014. Kalorama published its report on vaccine sales earlier this year.

Measles was largely eradicated in the United Sta...